Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.
Identifieur interne : 000289 ( Main/Exploration ); précédent : 000288; suivant : 000290Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.
Auteurs : Jessica Ferguson ; Joelle I. Rosser ; Orlando Quintero ; Jake Scott ; Aruna Subramanian ; Mohammad Gumma ; Angela Rogers ; Shanthi KappagodaSource :
- Emerging infectious diseases [ 1080-6059 ] ; 2020.
Descripteurs français
- KwdFr :
- AMP (analogues et dérivés), AMP (usage thérapeutique), Alanine (analogues et dérivés), Alanine (usage thérapeutique), Analyse de survie (MeSH), Asthme (physiopathologie), Asthme (épidémiologie), Azithromycine (usage thérapeutique), Betacoronavirus (pathogénicité), Broncho-pneumopathie chronique obstructive (physiopathologie), Broncho-pneumopathie chronique obstructive (épidémiologie), Californie (épidémiologie), Comorbidité (MeSH), Diabète (physiopathologie), Diabète (épidémiologie), Durée du séjour (MeSH), Femelle (MeSH), Humains (MeSH), Hyperlipidémies (physiopathologie), Hyperlipidémies (épidémiologie), Hypertension artérielle (physiopathologie), Hypertension artérielle (épidémiologie), Indice de gravité de la maladie (MeSH), Infections à coronavirus (diagnostic), Infections à coronavirus (mortalité), Infections à coronavirus (traitement médicamenteux), Infections à coronavirus (épidémiologie), Mâle (MeSH), Pandémies (MeSH), Pneumopathie virale (diagnostic), Pneumopathie virale (mortalité), Pneumopathie virale (traitement médicamenteux), Pneumopathie virale (épidémiologie), RT-PCR (MeSH), Sujet âgé (MeSH), Sujet âgé de 80 ans ou plus (MeSH), Techniques de laboratoire clinique (méthodes), Tomodensitométrie (MeSH), Unités de soins intensifs (MeSH), Études rétrospectives (MeSH).
- MESH :
- analogues et dérivés : AMP, Alanine.
- diagnostic : Infections à coronavirus, Pneumopathie virale.
- mortalité : Infections à coronavirus, Pneumopathie virale.
- méthodes : Techniques de laboratoire clinique.
- pathogénicité : Betacoronavirus.
- physiopathologie : Asthme, Broncho-pneumopathie chronique obstructive, Diabète, Hyperlipidémies, Hypertension artérielle.
- traitement médicamenteux : Infections à coronavirus, Pneumopathie virale.
- usage thérapeutique : AMP, Alanine, Azithromycine.
- épidémiologie : Asthme, Broncho-pneumopathie chronique obstructive, Californie, Diabète, Hyperlipidémies, Hypertension artérielle, Infections à coronavirus, Pneumopathie virale.
- Analyse de survie, Comorbidité, Durée du séjour, Femelle, Humains, Indice de gravité de la maladie, Mâle, Pandémies, RT-PCR, Sujet âgé, Sujet âgé de 80 ans ou plus, Tomodensitométrie, Unités de soins intensifs, Études rétrospectives.
English descriptors
- KwdEn :
- Adenosine Monophosphate (analogs & derivatives), Adenosine Monophosphate (therapeutic use), Aged (MeSH), Aged, 80 and over (MeSH), Alanine (analogs & derivatives), Alanine (therapeutic use), Asthma (epidemiology), Asthma (physiopathology), Azithromycin (therapeutic use), Betacoronavirus (pathogenicity), California (epidemiology), Clinical Laboratory Techniques (methods), Comorbidity (MeSH), Coronavirus Infections (diagnosis), Coronavirus Infections (drug therapy), Coronavirus Infections (epidemiology), Coronavirus Infections (mortality), Diabetes Mellitus (epidemiology), Diabetes Mellitus (physiopathology), Female (MeSH), Humans (MeSH), Hyperlipidemias (epidemiology), Hyperlipidemias (physiopathology), Hypertension (epidemiology), Hypertension (physiopathology), Intensive Care Units (MeSH), Length of Stay (MeSH), Male (MeSH), Pandemics (MeSH), Pneumonia, Viral (diagnosis), Pneumonia, Viral (drug therapy), Pneumonia, Viral (epidemiology), Pneumonia, Viral (mortality), Pulmonary Disease, Chronic Obstructive (epidemiology), Pulmonary Disease, Chronic Obstructive (physiopathology), Retrospective Studies (MeSH), Reverse Transcriptase Polymerase Chain Reaction (MeSH), Severity of Illness Index (MeSH), Survival Analysis (MeSH), Tomography, X-Ray Computed (MeSH).
- MESH :
- chemical , analogs & derivatives : Adenosine Monophosphate, Alanine.
- chemical , therapeutic use : Adenosine Monophosphate, Alanine, Azithromycin.
- geographic , epidemiology : California.
- diagnosis : Coronavirus Infections, Pneumonia, Viral.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- epidemiology : Asthma, Coronavirus Infections, Diabetes Mellitus, Hyperlipidemias, Hypertension, Pneumonia, Viral, Pulmonary Disease, Chronic Obstructive.
- methods : Clinical Laboratory Techniques.
- mortality : Coronavirus Infections, Pneumonia, Viral.
- pathogenicity : Betacoronavirus.
- physiopathology : Asthma, Diabetes Mellitus, Hyperlipidemias, Hypertension, Pulmonary Disease, Chronic Obstructive.
- Aged, Aged, 80 and over, Comorbidity, Female, Humans, Intensive Care Units, Length of Stay, Male, Pandemics, Retrospective Studies, Reverse Transcriptase Polymerase Chain Reaction, Severity of Illness Index, Survival Analysis, Tomography, X-Ray Computed.
Abstract
Limited data are available on the clinical presentation and outcomes of coronavirus disease (COVID-19) patients in the United States hospitalized under normal-caseload or nonsurge conditions. We retrospectively studied 72 consecutive adult patients hospitalized with COVID-19 in 2 hospitals in the San Francisco Bay area, California, USA, during March 13-April 11, 2020. The death rate for all hospitalized COVID-19 patients was 8.3%, and median length of hospitalization was 7.5 days. Of the 21 (29% of total) intensive care unit patients, 3 (14.3% died); median length of intensive care unit stay was 12 days. Of the 72 patients, 43 (59.7%) had underlying cardiovascular disease and 19 (26.4%) had underlying pulmonary disease. In this study, death rates were lower than those reported from regions of the United States experiencing a high volume of COVID-19 patients.
DOI: 10.3201/eid2608.201776
PubMed: 32407284
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.</title>
<author><name sortKey="Ferguson, Jessica" sort="Ferguson, Jessica" uniqKey="Ferguson J" first="Jessica" last="Ferguson">Jessica Ferguson</name>
</author>
<author><name sortKey="Rosser, Joelle I" sort="Rosser, Joelle I" uniqKey="Rosser J" first="Joelle I" last="Rosser">Joelle I. Rosser</name>
</author>
<author><name sortKey="Quintero, Orlando" sort="Quintero, Orlando" uniqKey="Quintero O" first="Orlando" last="Quintero">Orlando Quintero</name>
</author>
<author><name sortKey="Scott, Jake" sort="Scott, Jake" uniqKey="Scott J" first="Jake" last="Scott">Jake Scott</name>
</author>
<author><name sortKey="Subramanian, Aruna" sort="Subramanian, Aruna" uniqKey="Subramanian A" first="Aruna" last="Subramanian">Aruna Subramanian</name>
</author>
<author><name sortKey="Gumma, Mohammad" sort="Gumma, Mohammad" uniqKey="Gumma M" first="Mohammad" last="Gumma">Mohammad Gumma</name>
</author>
<author><name sortKey="Rogers, Angela" sort="Rogers, Angela" uniqKey="Rogers A" first="Angela" last="Rogers">Angela Rogers</name>
</author>
<author><name sortKey="Kappagoda, Shanthi" sort="Kappagoda, Shanthi" uniqKey="Kappagoda S" first="Shanthi" last="Kappagoda">Shanthi Kappagoda</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32407284</idno>
<idno type="pmid">32407284</idno>
<idno type="doi">10.3201/eid2608.201776</idno>
<idno type="wicri:Area/Main/Corpus">000281</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000281</idno>
<idno type="wicri:Area/Main/Curation">000281</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000281</idno>
<idno type="wicri:Area/Main/Exploration">000281</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.</title>
<author><name sortKey="Ferguson, Jessica" sort="Ferguson, Jessica" uniqKey="Ferguson J" first="Jessica" last="Ferguson">Jessica Ferguson</name>
</author>
<author><name sortKey="Rosser, Joelle I" sort="Rosser, Joelle I" uniqKey="Rosser J" first="Joelle I" last="Rosser">Joelle I. Rosser</name>
</author>
<author><name sortKey="Quintero, Orlando" sort="Quintero, Orlando" uniqKey="Quintero O" first="Orlando" last="Quintero">Orlando Quintero</name>
</author>
<author><name sortKey="Scott, Jake" sort="Scott, Jake" uniqKey="Scott J" first="Jake" last="Scott">Jake Scott</name>
</author>
<author><name sortKey="Subramanian, Aruna" sort="Subramanian, Aruna" uniqKey="Subramanian A" first="Aruna" last="Subramanian">Aruna Subramanian</name>
</author>
<author><name sortKey="Gumma, Mohammad" sort="Gumma, Mohammad" uniqKey="Gumma M" first="Mohammad" last="Gumma">Mohammad Gumma</name>
</author>
<author><name sortKey="Rogers, Angela" sort="Rogers, Angela" uniqKey="Rogers A" first="Angela" last="Rogers">Angela Rogers</name>
</author>
<author><name sortKey="Kappagoda, Shanthi" sort="Kappagoda, Shanthi" uniqKey="Kappagoda S" first="Shanthi" last="Kappagoda">Shanthi Kappagoda</name>
</author>
</analytic>
<series><title level="j">Emerging infectious diseases</title>
<idno type="eISSN">1080-6059</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenosine Monophosphate (analogs & derivatives)</term>
<term>Adenosine Monophosphate (therapeutic use)</term>
<term>Aged (MeSH)</term>
<term>Aged, 80 and over (MeSH)</term>
<term>Alanine (analogs & derivatives)</term>
<term>Alanine (therapeutic use)</term>
<term>Asthma (epidemiology)</term>
<term>Asthma (physiopathology)</term>
<term>Azithromycin (therapeutic use)</term>
<term>Betacoronavirus (pathogenicity)</term>
<term>California (epidemiology)</term>
<term>Clinical Laboratory Techniques (methods)</term>
<term>Comorbidity (MeSH)</term>
<term>Coronavirus Infections (diagnosis)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Coronavirus Infections (mortality)</term>
<term>Diabetes Mellitus (epidemiology)</term>
<term>Diabetes Mellitus (physiopathology)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hyperlipidemias (epidemiology)</term>
<term>Hyperlipidemias (physiopathology)</term>
<term>Hypertension (epidemiology)</term>
<term>Hypertension (physiopathology)</term>
<term>Intensive Care Units (MeSH)</term>
<term>Length of Stay (MeSH)</term>
<term>Male (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (diagnosis)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Pneumonia, Viral (mortality)</term>
<term>Pulmonary Disease, Chronic Obstructive (epidemiology)</term>
<term>Pulmonary Disease, Chronic Obstructive (physiopathology)</term>
<term>Retrospective Studies (MeSH)</term>
<term>Reverse Transcriptase Polymerase Chain Reaction (MeSH)</term>
<term>Severity of Illness Index (MeSH)</term>
<term>Survival Analysis (MeSH)</term>
<term>Tomography, X-Ray Computed (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>AMP (analogues et dérivés)</term>
<term>AMP (usage thérapeutique)</term>
<term>Alanine (analogues et dérivés)</term>
<term>Alanine (usage thérapeutique)</term>
<term>Analyse de survie (MeSH)</term>
<term>Asthme (physiopathologie)</term>
<term>Asthme (épidémiologie)</term>
<term>Azithromycine (usage thérapeutique)</term>
<term>Betacoronavirus (pathogénicité)</term>
<term>Broncho-pneumopathie chronique obstructive (physiopathologie)</term>
<term>Broncho-pneumopathie chronique obstructive (épidémiologie)</term>
<term>Californie (épidémiologie)</term>
<term>Comorbidité (MeSH)</term>
<term>Diabète (physiopathologie)</term>
<term>Diabète (épidémiologie)</term>
<term>Durée du séjour (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Hyperlipidémies (physiopathologie)</term>
<term>Hyperlipidémies (épidémiologie)</term>
<term>Hypertension artérielle (physiopathologie)</term>
<term>Hypertension artérielle (épidémiologie)</term>
<term>Indice de gravité de la maladie (MeSH)</term>
<term>Infections à coronavirus (diagnostic)</term>
<term>Infections à coronavirus (mortalité)</term>
<term>Infections à coronavirus (traitement médicamenteux)</term>
<term>Infections à coronavirus (épidémiologie)</term>
<term>Mâle (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (diagnostic)</term>
<term>Pneumopathie virale (mortalité)</term>
<term>Pneumopathie virale (traitement médicamenteux)</term>
<term>Pneumopathie virale (épidémiologie)</term>
<term>RT-PCR (MeSH)</term>
<term>Sujet âgé (MeSH)</term>
<term>Sujet âgé de 80 ans ou plus (MeSH)</term>
<term>Techniques de laboratoire clinique (méthodes)</term>
<term>Tomodensitométrie (MeSH)</term>
<term>Unités de soins intensifs (MeSH)</term>
<term>Études rétrospectives (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Adenosine Monophosphate</term>
<term>Alanine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adenosine Monophosphate</term>
<term>Alanine</term>
<term>Azithromycin</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>California</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>AMP</term>
<term>Alanine</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Asthma</term>
<term>Coronavirus Infections</term>
<term>Diabetes Mellitus</term>
<term>Hyperlipidemias</term>
<term>Hypertension</term>
<term>Pneumonia, Viral</term>
<term>Pulmonary Disease, Chronic Obstructive</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Clinical Laboratory Techniques</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Techniques de laboratoire clinique</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Asthme</term>
<term>Broncho-pneumopathie chronique obstructive</term>
<term>Diabète</term>
<term>Hyperlipidémies</term>
<term>Hypertension artérielle</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Asthma</term>
<term>Diabetes Mellitus</term>
<term>Hyperlipidemias</term>
<term>Hypertension</term>
<term>Pulmonary Disease, Chronic Obstructive</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>AMP</term>
<term>Alanine</term>
<term>Azithromycine</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Asthme</term>
<term>Broncho-pneumopathie chronique obstructive</term>
<term>Californie</term>
<term>Diabète</term>
<term>Hyperlipidémies</term>
<term>Hypertension artérielle</term>
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Comorbidity</term>
<term>Female</term>
<term>Humans</term>
<term>Intensive Care Units</term>
<term>Length of Stay</term>
<term>Male</term>
<term>Pandemics</term>
<term>Retrospective Studies</term>
<term>Reverse Transcriptase Polymerase Chain Reaction</term>
<term>Severity of Illness Index</term>
<term>Survival Analysis</term>
<term>Tomography, X-Ray Computed</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Analyse de survie</term>
<term>Comorbidité</term>
<term>Durée du séjour</term>
<term>Femelle</term>
<term>Humains</term>
<term>Indice de gravité de la maladie</term>
<term>Mâle</term>
<term>Pandémies</term>
<term>RT-PCR</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Tomodensitométrie</term>
<term>Unités de soins intensifs</term>
<term>Études rétrospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Limited data are available on the clinical presentation and outcomes of coronavirus disease (COVID-19) patients in the United States hospitalized under normal-caseload or nonsurge conditions. We retrospectively studied 72 consecutive adult patients hospitalized with COVID-19 in 2 hospitals in the San Francisco Bay area, California, USA, during March 13-April 11, 2020. The death rate for all hospitalized COVID-19 patients was 8.3%, and median length of hospitalization was 7.5 days. Of the 21 (29% of total) intensive care unit patients, 3 (14.3% died); median length of intensive care unit stay was 12 days. Of the 72 patients, 43 (59.7%) had underlying cardiovascular disease and 19 (26.4%) had underlying pulmonary disease. In this study, death rates were lower than those reported from regions of the United States experiencing a high volume of COVID-19 patients.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32407284</PMID>
<DateCompleted><Year>2020</Year>
<Month>07</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>07</Month>
<Day>29</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1080-6059</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>26</Volume>
<Issue>8</Issue>
<PubDate><Year>2020</Year>
<Month>08</Month>
</PubDate>
</JournalIssue>
<Title>Emerging infectious diseases</Title>
<ISOAbbreviation>Emerging Infect. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.</ArticleTitle>
<Pagination><MedlinePgn>1679-1685</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3201/eid2608.201776</ELocationID>
<Abstract><AbstractText>Limited data are available on the clinical presentation and outcomes of coronavirus disease (COVID-19) patients in the United States hospitalized under normal-caseload or nonsurge conditions. We retrospectively studied 72 consecutive adult patients hospitalized with COVID-19 in 2 hospitals in the San Francisco Bay area, California, USA, during March 13-April 11, 2020. The death rate for all hospitalized COVID-19 patients was 8.3%, and median length of hospitalization was 7.5 days. Of the 21 (29% of total) intensive care unit patients, 3 (14.3% died); median length of intensive care unit stay was 12 days. Of the 72 patients, 43 (59.7%) had underlying cardiovascular disease and 19 (26.4%) had underlying pulmonary disease. In this study, death rates were lower than those reported from regions of the United States experiencing a high volume of COVID-19 patients.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ferguson</LastName>
<ForeName>Jessica</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Rosser</LastName>
<ForeName>Joelle I</ForeName>
<Initials>JI</Initials>
</Author>
<Author ValidYN="Y"><LastName>Quintero</LastName>
<ForeName>Orlando</ForeName>
<Initials>O</Initials>
</Author>
<Author ValidYN="Y"><LastName>Scott</LastName>
<ForeName>Jake</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Subramanian</LastName>
<ForeName>Aruna</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Gumma</LastName>
<ForeName>Mohammad</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Rogers</LastName>
<ForeName>Angela</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kappagoda</LastName>
<ForeName>Shanthi</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>T32 AI052073</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D064888">Observational Study</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>05</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Emerg Infect Dis</MedlineTA>
<NlmUniqueID>9508155</NlmUniqueID>
<ISSNLinking>1080-6040</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>3QKI37EEHE</RegistryNumber>
<NameOfSubstance UI="C000606551">remdesivir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>415SHH325A</RegistryNumber>
<NameOfSubstance UI="D000249">Adenosine Monophosphate</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>83905-01-5</RegistryNumber>
<NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>OF5P57N2ZX</RegistryNumber>
<NameOfSubstance UI="D000409">Alanine</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Protocol" UI="C000657964">COVID-19 diagnostic testing</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000249" MajorTopicYN="N">Adenosine Monophosphate</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000409" MajorTopicYN="N">Alanine</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017963" MajorTopicYN="N">Azithromycin</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002140" MajorTopicYN="N" Type="Geographic">California</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019411" MajorTopicYN="N">Clinical Laboratory Techniques</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003920" MajorTopicYN="N">Diabetes Mellitus</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006949" MajorTopicYN="N">Hyperlipidemias</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D029424" MajorTopicYN="N">Pulmonary Disease, Chronic Obstructive</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">COVID-19</Keyword>
<Keyword MajorTopicYN="Y">California</Keyword>
<Keyword MajorTopicYN="Y">Coronavirus diseases</Keyword>
<Keyword MajorTopicYN="Y">ICU</Keyword>
<Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
<Keyword MajorTopicYN="Y">United States</Keyword>
<Keyword MajorTopicYN="Y">coronavirus disease</Keyword>
<Keyword MajorTopicYN="Y">hospitalization</Keyword>
<Keyword MajorTopicYN="Y">mortality</Keyword>
<Keyword MajorTopicYN="Y">outcomes</Keyword>
<Keyword MajorTopicYN="Y">pneumonia</Keyword>
<Keyword MajorTopicYN="Y">respiratory diseases</Keyword>
<Keyword MajorTopicYN="Y">severe acute respiratory syndrome coronavirus 2</Keyword>
<Keyword MajorTopicYN="Y">viruses</Keyword>
<Keyword MajorTopicYN="Y">zoonoses</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>5</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>7</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>5</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32407284</ArticleId>
<ArticleId IdType="doi">10.3201/eid2608.201776</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list></list>
<tree><noCountry><name sortKey="Ferguson, Jessica" sort="Ferguson, Jessica" uniqKey="Ferguson J" first="Jessica" last="Ferguson">Jessica Ferguson</name>
<name sortKey="Gumma, Mohammad" sort="Gumma, Mohammad" uniqKey="Gumma M" first="Mohammad" last="Gumma">Mohammad Gumma</name>
<name sortKey="Kappagoda, Shanthi" sort="Kappagoda, Shanthi" uniqKey="Kappagoda S" first="Shanthi" last="Kappagoda">Shanthi Kappagoda</name>
<name sortKey="Quintero, Orlando" sort="Quintero, Orlando" uniqKey="Quintero O" first="Orlando" last="Quintero">Orlando Quintero</name>
<name sortKey="Rogers, Angela" sort="Rogers, Angela" uniqKey="Rogers A" first="Angela" last="Rogers">Angela Rogers</name>
<name sortKey="Rosser, Joelle I" sort="Rosser, Joelle I" uniqKey="Rosser J" first="Joelle I" last="Rosser">Joelle I. Rosser</name>
<name sortKey="Scott, Jake" sort="Scott, Jake" uniqKey="Scott J" first="Jake" last="Scott">Jake Scott</name>
<name sortKey="Subramanian, Aruna" sort="Subramanian, Aruna" uniqKey="Subramanian A" first="Aruna" last="Subramanian">Aruna Subramanian</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CardioCovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000289 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000289 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CardioCovidV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:32407284 |texte= Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32407284" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a CardioCovidV1
This area was generated with Dilib version V0.6.35. |